A preliminary benefit-risk assessment of varenicline in smoking cessation. by Cahill, K, Stead, L, Lancaster, T

“…Varenicline is a recently developed medication for smoking cessation, which has been available on prescription since 2006. …”

Behavioural interventions for smoking cessation: An overview and network meta‐analysis by Hartmann-Boyce, J, Livingstone-Banks, J, Ordóñez-Mena, JM, Fanshawe, TR, Lindson, N, Freeman, SC, Sutton, AJ, Theodoulou, A, Aveyard, P

“…The effect of behavioural support for smoking cessation appeared slightly less pronounced when people were already receiving smoking cessation pharmacotherapies.…”

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. by Cahill, K, Ussher, M

“…It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. …”

Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. by Silagy, C, Mant, D, Fowler, G, Lodge, M

“…We conclude that the currently available forms of NRT are effective therapies to aid smoking cessation.…”

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. by Cahill, K, Ussher, M

“…It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. …”

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. by Cahill, K, Ussher, M

“…It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. …”

Smoking cessation 1: Choosing the right pharmacotherapy for each patient by Aveyard, P, Parsons, A, Begh, R

Behavioural interventions for smoking cessation: an overview and network meta‐analysis by Hartmann-Boyce, J, Fanshawe, T, Lindson, N, Livingstone-Banks, J, Ordóñez‐Mena, J, Aveyard, P

“…The objectives are as follows: The primary objectives are to summarise the evidence from Cochrane Reviews that assessed the effect of behavioural interventions designed to support smoking cessation attempts, and address the following two questions: How do modes of delivery, person delivering the intervention, and the behavioural and motivational components of behavioural interventions for smoking cessation compare with each other in achieving abstinence at follow‐up of six months or longer? …”

Promoting smoking cessation through smoking reduction during Ramadan. by Aveyard, P, Begh, R, Sheikh, A, Amos, A

Dental students as smoking cessation counsellors: Patients' and providers' perspective by Mohd Nor, Nor Azlida, Repen, Marvin Costher, Zakaria, Zakuan, Ab-Murat, Norintan, Saub, Roslan, Razak, Ishak Abdul

“…Introduction: This study assesses dental students' and patients' perceptions on the role of dental students as smoking cessation counsellors as well as the patient's quit rate at the University of XX. …”

Food Addiction Does Not Explain Weight Gain in Smoking Cessation by Amer Nordin, Amer Siddiq, Adamson, Simon Justin, Sellman, John Douglas

“…Introduction: Weight gain during smoking cessation is a major concern. The relationship between smoking and weight is complex and not well understood. …”

Knowledge, attitudes, and capabilities for smoking cessation counselling in dental practice by Yahya, Nurul Asyikin, Saub, Roslan, Md Nor, Mariani

“…Public dentists had more knowledge, skills and a positive attitude about providing smoking cessation counselling than private dentists. More public dentists felt they had inadequate time and lack of a support system to follow-up on smoking cessation counselling than private dentists.…”

Nicotine-replacement therapy: a proven treatment for smoking cessation by Robson, Noor Zurani

“…This article aims to review the role of NRT in smoking cessation.…”
Get full text

Job stressors and smoking cessation among Malaysian male employees by Yasin, Siti Munira, Retneswari, Masilamani, Moy, Foong Ming, Darus, A., Koh, David

“…To assess the association between job strain, smoking behaviour and smoking cessation among Malaysian male employees involved in a smoking cessation programme. …”
Get full text

Outcome and predictors for smoking cessation in a quit smoking clinic by Zainal Abidin, Muhammad Adil, Kadi @ Shahar, Hayati, Abdul Manaf, Rosliza

“…Introduction: Smoking is one of the addiction problems that needs an effective intervention. Smoking cessation studies have shown the promising result, but the central issue was to prevent relapse. …”
Get full text

A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation. by Parsons, A, Ingram, J, Inglis, J, Aveyard, P, Johnstone, E, Brown, K, Franklin, M, Bermudez, I

“…CONCLUSIONS: Taking together the absolute quit rates, the small difference between active and placebo, and lack of effects on withdrawal shows that SJW is ineffective for smoking cessation. Insufficient people stopped smoking to properly test the efficacy of chromium in preventing weight gain, but the point estimate indicates a potentially worthwhile benefit.…”

Outcome criteria in smoking cessation trials: proposal for a common standard. by West, R, Hajek, P, Stead, L, Stapleton, J

“…Smoking cessation treatment is now integrated into many health-care systems and a major research effort is under way to improve current success rates. …”

Smoking cessation and changes in anxiety and depression in adults with and without psychiatric disorders by Wu, AD, Gao, M, Aveyard, P, Taylor, G

“…</p> <p><strong>Objective:</strong> To assess changes in mental health following smoking cessation using 3 confirmatory coprimary analytical approaches.…”

Psychometric properties of the processes of change scale for smoking cessation in UK adolescents. by Guo, B, Fielding, A, Sutton, S, Aveyard, P

Smoking cessation pharmacotherapy based on genetically-informed biomarkers: what is the evidence? by Panagiotou, OA, Schuit, E, Munafò, MR, Bennett, DA, Bergen, AW, David, SP

“…<p><strong>Introduction:</strong> Pharmacogenomic studies have used genetic variants to identify smokers likely to respond to pharmacological treatments for smoking cessation. Methods:We performed a systematic review and meta-analysis of primary and secondary analyses of trials of smoking cessation pharmacotherapies. …”